PL378035A1 - Transdermalny system terapeutyczny w postaci plastra odporny na działanie promieniowania UV - Google Patents
Transdermalny system terapeutyczny w postaci plastra odporny na działanie promieniowania UVInfo
- Publication number
- PL378035A1 PL378035A1 PL378035A PL37803504A PL378035A1 PL 378035 A1 PL378035 A1 PL 378035A1 PL 378035 A PL378035 A PL 378035A PL 37803504 A PL37803504 A PL 37803504A PL 378035 A1 PL378035 A1 PL 378035A1
- Authority
- PL
- Poland
- Prior art keywords
- absorber
- transdermal therapeutic
- active substance
- matrix containing
- matrix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Wynalazek dotyczy transdermalnego systemu terapeutycznego (ang. Transdermal therapeutic system, w skrócie TTS) odpornego na działanie promieniowania UV, który to system obejmuje warstwę podkładową, przynajmniej jedną matrycę zawierającą substancję czynną oraz ewentualnie usuwaną folię i absorber promieniowania UV. Między warstwą podkładową a matrycą zawierającą substancję czynną, która to matryca oddalona jest w maksymalnym stopniu od powierzchni skóry, rozmieszczona jest przynajmniej jedna warstwa klejąca, w skład której wchodzi wspomniany absorber promieniowania UV, zaś między warstwą klejącą, w skład której wchodzi absorber promieniowania UV, a matrycą zawierającą substancję czynną, która to matryca oddalona jest w maksymalnym stopniu od powierzchni skóry, znajduje się przynajmniej jedna warstwa rozdzielcza, nieprzepuszczalna dla substancji czynnej oraz absorbera promieniowania UV. Transdermalny system terapeutyczny według wynalazku odznacza się wysoką stabilnością, zarazem nie powodując niedogodności typowych dla systemów TTS zawierających substancje czynne wrażliwe na działanie światła.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03003888A EP1449526A1 (de) | 2003-02-21 | 2003-02-21 | UV-stabiles transdermales Pflaster |
EP03004061A EP1452173A1 (de) | 2003-02-25 | 2003-02-25 | UV-stabiles transdermales Pflaster |
Publications (2)
Publication Number | Publication Date |
---|---|
PL378035A1 true PL378035A1 (pl) | 2006-02-20 |
PL219030B1 PL219030B1 (pl) | 2015-03-31 |
Family
ID=32910125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL378035A PL219030B1 (pl) | 2003-02-21 | 2004-02-04 | Transdermalny system terapeutyczny w postaci plastra odporny na działanie promieniowania UV |
Country Status (31)
Country | Link |
---|---|
US (3) | US8486443B2 (pl) |
EP (1) | EP1594483B1 (pl) |
JP (1) | JP4528296B2 (pl) |
KR (1) | KR100704825B1 (pl) |
AR (1) | AR043248A1 (pl) |
AT (1) | ATE333271T1 (pl) |
AU (1) | AU2004212675B2 (pl) |
BR (1) | BRPI0407615B8 (pl) |
CA (1) | CA2515918C (pl) |
CR (1) | CR7952A (pl) |
CY (1) | CY1105716T1 (pl) |
DE (1) | DE502004000988D1 (pl) |
DK (1) | DK1594483T3 (pl) |
EA (1) | EA008098B1 (pl) |
EC (1) | ECSP056030A (pl) |
ES (1) | ES2270345T3 (pl) |
HK (1) | HK1085394A1 (pl) |
HR (1) | HRP20050828B1 (pl) |
IL (1) | IL170295A (pl) |
IS (1) | IS2541B (pl) |
ME (2) | ME00147B (pl) |
MX (1) | MXPA05008778A (pl) |
NO (1) | NO336108B1 (pl) |
NZ (1) | NZ541807A (pl) |
PE (1) | PE20041028A1 (pl) |
PL (1) | PL219030B1 (pl) |
PT (1) | PT1594483E (pl) |
RS (1) | RS50428B (pl) |
SI (1) | SI1594483T1 (pl) |
UY (1) | UY28189A1 (pl) |
WO (1) | WO2004073696A1 (pl) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1594483B1 (de) | 2003-02-21 | 2006-07-19 | Schering AG | Uv-stabiles transdermales pflaster |
US8668925B2 (en) | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
CN101005833A (zh) * | 2004-08-20 | 2007-07-25 | 3M创新有限公司 | 具有半透明保护膜的透皮药物递送装置 |
EP1719504A1 (de) * | 2005-05-02 | 2006-11-08 | Schering AG | Festes transdermales therapeutisches System mit UV-Absorber |
US8962013B2 (en) * | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
US20100008966A1 (en) * | 2008-07-14 | 2010-01-14 | Surmodics, Inc. | Medical Devices and Methods for Delivery of Nucleic Acids |
CN103189064B (zh) | 2010-09-06 | 2015-08-12 | 拜耳知识产权有限责任公司 | 具有高药物释放的低剂量透皮贴剂 |
DE102010040299A1 (de) * | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然の併用ホルモン補充療法剤及び療法 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
RU2737464C2 (ru) | 2015-12-30 | 2020-11-30 | Кориум Интернэшнл, Инк. | Системы и способы длительного трансдермального введения |
KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
DE102020104907A1 (de) * | 2020-02-25 | 2021-08-26 | Berliner Glas GmbH | Verfahren zur Herstellung eines Bauelements durch atomares Diffusionsbonden |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5939827A (ja) | 1982-08-27 | 1984-03-05 | Nitto Electric Ind Co Ltd | 医療用外用部材 |
JPS6069014A (ja) | 1983-09-27 | 1985-04-19 | Nitto Electric Ind Co Ltd | 皮膚疾患治療用貼付剤 |
US4573996A (en) * | 1984-01-03 | 1986-03-04 | Jonergin, Inc. | Device for the administration of an active agent to the skin or mucosa |
JPS60166611A (ja) | 1984-02-10 | 1985-08-29 | Nitto Electric Ind Co Ltd | 疾患治療用部材 |
US5560922A (en) | 1986-05-30 | 1996-10-01 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process |
US5023084A (en) | 1986-12-29 | 1991-06-11 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
CH674618A5 (pl) | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag | |
US5538736A (en) | 1987-04-28 | 1996-07-23 | Lts Lohmann Therapie-Systeme Gmbh | Active substance-containing plaster for the controlled administration of active substances to the skin |
US5128284A (en) | 1987-10-23 | 1992-07-07 | Allied-Signal Inc. | Preparation of lanthanum chromite powders by sol-gel |
WO1990004397A1 (de) | 1988-10-27 | 1990-05-03 | Schering Aktiengesellschaft Berlin Und Bergkamen | Mittel zur transdermalen applikation enthaltend gestoden |
EP0453396B1 (de) | 1990-03-30 | 1995-12-13 | Ciba SC Holding AG | Lackzusammensetzungen |
AU633733B2 (en) | 1990-05-17 | 1993-02-04 | Hisamitsu Pharmaceutical Co., Inc. | Percutaneous preparation containing estradiol |
GB9021674D0 (en) | 1990-10-05 | 1990-11-21 | Ethical Pharma Ltd | Transdermal device |
US5512292A (en) | 1990-10-29 | 1996-04-30 | Alza Corporation | Transdermal contraceptive formulations methods and devices |
PT99338A (pt) | 1990-10-29 | 1992-10-30 | Alza Corp | Processo para a preparacao de composicoes de farmacos anticoncepcionais administradas transdermicamente contendo uma mistura dum estrogeno e gestodeno e dispositivos para a sua administracao transdermica |
JP3112707B2 (ja) | 1991-07-25 | 2000-11-27 | 日本電気株式会社 | 監視システム用ポーリング方式 |
DE4336557C2 (de) | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
DE4329242A1 (de) * | 1993-08-26 | 1995-03-02 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Gestodenester |
DE4336299A1 (de) * | 1993-10-25 | 1995-05-11 | Arbo Robotron Medizin Technolo | Gelkörper zur percutanen Verabreichung, insbesondere von Medikamenten |
DE4403487C2 (de) * | 1994-02-04 | 2003-10-16 | Lohmann Therapie Syst Lts | Arznei-Pflaster mit UV-vernetzbaren Acrylat-Copolymeren |
DE4405898A1 (de) | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
EP0787488A4 (en) | 1994-11-18 | 1998-06-03 | Hisamitsu Pharmaceutical Co | TRANSDERMAL ABSORBABLE PLASTER |
JP3908795B2 (ja) | 1994-11-29 | 2007-04-25 | 久光製薬株式会社 | ケトチフェン含有経皮投与製剤 |
CN1188189C (zh) | 1995-06-07 | 2005-02-09 | 奥瑟-麦内尔制药公司 | 基质层含有17-脱乙酰基诺孕酯的经皮贴片及基质的用途 |
US5906830A (en) | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
JP3626275B2 (ja) | 1996-04-09 | 2005-03-02 | Jsr株式会社 | 光硬化性樹脂組成物 |
US5762956A (en) | 1996-04-24 | 1998-06-09 | Rutgers, The State University Of New Jersey | Transdermal contraceptive delivery system and process |
JP4346696B2 (ja) | 1996-05-28 | 2009-10-21 | 久光製薬株式会社 | 経皮治療用装置 |
JP3434135B2 (ja) | 1996-07-11 | 2003-08-04 | アルパイン株式会社 | ナビゲーション装置 |
DE19701949A1 (de) | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermales therapeutisches System |
JPH10265371A (ja) * | 1997-03-25 | 1998-10-06 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
ID23512A (id) | 1997-04-16 | 2000-04-27 | Hisamitsu Pharmaceutical Co | Komposisi dasar untuk penyerapan melalui kulit dan sediaan yang dapat diserap melalui kulit yang mengandung komposisi dasar |
US5948433A (en) | 1997-08-21 | 1999-09-07 | Bertek, Inc. | Transdermal patch |
DE19827732A1 (de) | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
JP4399044B2 (ja) | 1998-10-14 | 2010-01-13 | 久光製薬株式会社 | 吸収促進剤及び該吸収促進剤を有してなる経皮吸収製剤 |
AU3478200A (en) | 1999-02-02 | 2000-08-25 | Ortho-Mcneil Pharmaceutical, Inc. | Method of manufacture for transdermal matrices |
DE19906152B4 (de) | 1999-02-10 | 2005-02-10 | Jenapharm Gmbh & Co. Kg | Wirkstoffhaltige Laminate für Transdermalsysteme |
DE19912623A1 (de) | 1999-03-20 | 2000-09-28 | Lohmann Therapie Syst Lts | Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile |
US8173592B1 (en) | 1999-03-31 | 2012-05-08 | Zentaris Ivf Gmbh | Method for a programmed controlled ovarian stimulation protocol |
EP1197212A4 (en) | 1999-07-01 | 2004-06-02 | Hisamitsu Pharmaceutical Co | ADHESIVE COMPOSITION FOR PERCUTANE ABSORPTION |
PT1242012E (pt) | 1999-11-24 | 2010-03-31 | Agile Therapeutics Inc | Sistema e processo melhorado de libertação transdérmica de contraceptivo |
US20020004065A1 (en) | 2000-01-20 | 2002-01-10 | David Kanios | Compositions and methods to effect the release profile in the transdermal administration of active agents |
CN1245961C (zh) | 2000-03-17 | 2006-03-22 | 久光制药株式会社 | 紫外遮蔽性贴剂 |
AU6425601A (en) * | 2000-06-13 | 2001-12-24 | Hisamitsu Pharmaceutical Co | Plaster |
DE10053375C1 (de) * | 2000-10-27 | 2002-01-24 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
AU2002235155A1 (en) | 2000-12-05 | 2002-06-18 | Noven Pharmaceuticals, Inc. | Crystallization inhibition of drugs in transdermal drug delivery systems |
EP1485103A1 (en) | 2002-03-11 | 2004-12-15 | Janssen Pharmaceutica N.V. | Sulfatase inhibiting continuous progestogen contraceptive regimens |
US6872401B2 (en) | 2002-03-28 | 2005-03-29 | L'oreal | Cosmetic/dermatological compositions comprising a tetrahydrocurcuminoid and an amide oil |
US7470452B1 (en) | 2002-06-13 | 2008-12-30 | E. I. Du Pont De Nemours & Company | Process for multilayer coating of substrates |
US7032980B2 (en) * | 2002-06-27 | 2006-04-25 | The Little Tikes Company | Non-slip wheel for a child's toy |
DE10261696A1 (de) | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base |
EP1594483B1 (de) | 2003-02-21 | 2006-07-19 | Schering AG | Uv-stabiles transdermales pflaster |
EP1452173A1 (de) | 2003-02-25 | 2004-09-01 | Schering AG | UV-stabiles transdermales Pflaster |
US8524272B2 (en) * | 2003-08-15 | 2013-09-03 | Mylan Technologies, Inc. | Transdermal patch incorporating active agent migration barrier layer |
DE602004018156D1 (de) | 2003-08-25 | 2009-01-15 | Bfs Diversified Products Llc | Verfahren und vorrichtung zur überwachung der druckfestigkeit von isolierplatten |
CN100415777C (zh) | 2003-09-11 | 2008-09-03 | 西巴特殊化学品控股有限公司 | 通过多相聚合技术制备的光稳定剂水基浓缩产品形式 |
US20050129756A1 (en) | 2003-12-10 | 2005-06-16 | Hans-Peter Podhaisky | UV-stable, liquid or semisolid transdermal pharmaceutical preparation with light sensitive active ingredient |
US8668925B2 (en) | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
EA011160B1 (ru) | 2003-12-12 | 2009-02-27 | Шеринг Акциенгезельшафт | Композиция для трансдермальной доставки гормонов без необходимости использования агентов, усиливающих проникновение, и ее применения |
UA89766C2 (en) | 2003-12-12 | 2010-03-10 | Байер Шеринг Фарма Акциенгезельшафт | Transdermal delivery system of gestodene |
JP4504109B2 (ja) | 2004-06-15 | 2010-07-14 | 株式会社新陽社 | 画像表示装置及び画素構成体 |
EP1719504A1 (de) | 2005-05-02 | 2006-11-08 | Schering AG | Festes transdermales therapeutisches System mit UV-Absorber |
US8962013B2 (en) | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
JP2012504609A (ja) | 2008-10-06 | 2012-02-23 | マイラン・テクノロジーズ,インコーポレイテッド | アモルファスロチゴチン経皮システム |
-
2004
- 2004-02-04 EP EP04707912A patent/EP1594483B1/de not_active Expired - Lifetime
- 2004-02-04 KR KR1020057015351A patent/KR100704825B1/ko active IP Right Grant
- 2004-02-04 US US10/545,826 patent/US8486443B2/en active Active
- 2004-02-04 DE DE502004000988T patent/DE502004000988D1/de not_active Expired - Lifetime
- 2004-02-04 MX MXPA05008778A patent/MXPA05008778A/es active IP Right Grant
- 2004-02-04 SI SI200430077T patent/SI1594483T1/sl unknown
- 2004-02-04 ME MEP-2008-140A patent/ME00147B/me unknown
- 2004-02-04 EA EA200501224A patent/EA008098B1/ru not_active IP Right Cessation
- 2004-02-04 PT PT04707912T patent/PT1594483E/pt unknown
- 2004-02-04 ME MEP-140/08A patent/MEP14008A/xx unknown
- 2004-02-04 NZ NZ541807A patent/NZ541807A/xx not_active IP Right Cessation
- 2004-02-04 DK DK04707912T patent/DK1594483T3/da active
- 2004-02-04 PL PL378035A patent/PL219030B1/pl unknown
- 2004-02-04 RS YUP-2005/0639A patent/RS50428B/sr unknown
- 2004-02-04 CA CA2515918A patent/CA2515918C/en not_active Expired - Lifetime
- 2004-02-04 AU AU2004212675A patent/AU2004212675B2/en not_active Ceased
- 2004-02-04 JP JP2006501740A patent/JP4528296B2/ja not_active Expired - Fee Related
- 2004-02-04 AT AT04707912T patent/ATE333271T1/de active
- 2004-02-04 WO PCT/EP2004/001052 patent/WO2004073696A1/de active IP Right Grant
- 2004-02-04 ES ES04707912T patent/ES2270345T3/es not_active Expired - Lifetime
- 2004-02-04 BR BRPI0407615A patent/BRPI0407615B8/pt not_active IP Right Cessation
- 2004-02-17 UY UY28189A patent/UY28189A1/es active IP Right Grant
- 2004-02-19 PE PE2004000172A patent/PE20041028A1/es active IP Right Grant
- 2004-02-20 AR ARP040100539A patent/AR043248A1/es not_active Application Discontinuation
-
2005
- 2005-08-16 IL IL170295A patent/IL170295A/en active IP Right Grant
- 2005-08-19 CR CR7952A patent/CR7952A/es unknown
- 2005-09-15 IS IS8031A patent/IS2541B/is unknown
- 2005-09-20 EC EC2005006030A patent/ECSP056030A/es unknown
- 2005-09-20 HR HRP20050828AA patent/HRP20050828B1/hr not_active IP Right Cessation
- 2005-09-20 NO NO20054321A patent/NO336108B1/no not_active IP Right Cessation
-
2006
- 2006-05-12 HK HK06105534.6A patent/HK1085394A1/xx not_active IP Right Cessation
- 2006-10-19 CY CY20061101501T patent/CY1105716T1/el unknown
-
2013
- 2013-03-15 US US13/835,723 patent/US9095691B2/en not_active Expired - Lifetime
-
2015
- 2015-07-29 US US14/812,431 patent/US20150335658A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL378035A1 (pl) | Transdermalny system terapeutyczny w postaci plastra odporny na działanie promieniowania UV | |
AR097045A2 (es) | Sistema terapéutico transdérmico | |
ES2581985T3 (es) | Sistema terapéutico transdérmico que contiene norelgestromina para la contracepción y el reemplazo hormonal | |
CY1109954T1 (el) | Διαδερμικο θεραπευτικο συστημα (tts) με τη δραστικη ουσια φεντανυλη | |
CY1106468T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
DK1381352T3 (da) | Plaster til transdermal indgivelse af fentanyl | |
BR122016030094B8 (pt) | cápsula, tablete, grânulo ou grânulo fino, e, cápsula de liberação prolongada | |
BR0313092A (pt) | Sistema de liberação transdérmica aperfeiçoado | |
AR028525A1 (es) | Sistema terapeutico transdermal para la administracion de lerisetron | |
ATE507831T1 (de) | Melatonin enthaltende pharmazeutische formulierung | |
CY1115757T1 (el) | Στερεο διαδερμικο θεραπευτικο συστημα που περιλαμβανει uv-απορροφητη | |
IS6172A (is) | Notkun melatoníns til lækninga | |
DK1587500T3 (da) | Forbindelser til oral dosering af et aktivt stof, der kræver smagsmaskering | |
UA87291C2 (ru) | Пероральное пленкообразное лекарственное средство дезоксипеганина и способ его применения | |
DK1404341T3 (da) | Kombination af aktive substanser til farmakologisk terapi af nikotinafhængighed | |
ATE529099T1 (de) | Pharmazeutische einzeldosisform | |
AR037405A1 (es) | Sistema terapeutico transdermal para la administracion de 17alfa-estradiol | |
CU23518A3 (es) | Sistema terapéutico transdérmico estable a los rayos ultravioletas | |
ATE303135T1 (de) | Pharmazeutische formulierungen zur gesteuerten freisetzung von 4-amino-6,7-dimethoxy-2-(5- | |
CY1114057T1 (el) | Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης | |
FIU20020437U0 (fi) | Leikkopuun jalka |